Table 2 |
||||||||
|
Physiological markers of inflammation in response to supplementation |
||||||||
|
Men |
Women |
|||||||
|
|
||||||||
|
Variables |
Pre Placebo |
Post Placebo |
Pre Suppl |
Post Suppl |
Pre Placebo |
Post Placebo |
Pre Suppl |
Post Suppl |
|
|
||||||||
|
M ± SD |
M ± SD |
M ± SD |
M ± SD |
M ± SD |
M ± SD |
M ± SD |
M ± SD |
|
|
|
||||||||
|
Creatine Kinase (IU·L-1) |
92 ± 25 |
80 ± 32 |
96 ± 34 |
67 ± 23* |
68 ± 42 |
69 ± 50 |
66 ± 32 |
62 ± 33 |
|
|
||||||||
|
Cortisol (nmol·L-1) |
557 ± 169 |
613 ± 128 |
524 ± 180 |
515 ± 187 |
560 ± 149 |
513 ± 129 |
518 ± 165 |
541 ± 148 |
|
|
||||||||
|
C-Reactive Protein (mg·dL-1) |
0.22 ± 0.25 |
0.19 ± 0.25 |
0.17 ± 0.24 |
0.19 ± 0.22 |
0.10 ± 0.10 |
0.11 ± 0.09 |
0.1 ± 0.1 |
0.12 ± 0.11 |
|
|
||||||||
|
Brachial Artery Reactivity (mm) |
4.6 ± 0.7 |
4.8 ± 0.7 |
4.7 ± 0.8 |
4.9 ± 0.8 |
3.7 ± 0.6 |
4.1 ± 0.6 |
3.8 ± 0.5 |
4.1 ± 0.5 |
|
|
||||||||
|
No significant differences were seen for placebo (either pre/post placebo or as compared to pre-supplementation). Pre Suppl = Pre-Supplementation testing; Post Suppl = Post-Supplementation testing. *p ≤ 0.05 as compared to supplementation pre-testing. |
||||||||
|
Dunn-Lewis et al. Nutrition Journal 2011 10:90 doi:10.1186/1475-2891-10-90 |
||||||||